๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Stability-indicating study of the anti-Alzheimer's drug galantamine hydrobromide

โœ Scribed by Lygia Azevedo Marques; Ismail Maada; Frans J.J. de Kanter; Henk Lingeman; Hubertus Irth; Wilfried M.A. Niessen; Martin Giera

Book ID
108189877
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
524 KB
Volume
55
Category
Article
ISSN
0731-7085

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Measuring the effects of anti-dementia d
Measuring the effects of anti-dementia drugs in patients with Alzheimer's disease
โœ S. Curran; J. P. Wattis ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 179 KB ๐Ÿ‘ 2 views

A large number of experimental compounds are being developed for the treatment of patients with Alzheimer's disease (AD). As dierent compounds may have dierent eects on CNS function, depending on which neurotransmitters they aect, adequate proยฎling will require the use of several tests. The dicultie

A multinational, randomised, 12-week stu
A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease
โœ Roy W. Jones; Hilkka Soininen; Klaus Hager; Dag Aarsland; Peter Passmore; Anita ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 180 KB ๐Ÿ‘ 2 views

## Abstract ## Objectives To compare directly, in the same patient cohort, the ease of use and tolerability of donepezil and galantamine in the treatment of Alzheimer's disease (AD), and investigate the effects of both treatments on cognition and activities of daily living (ADL). ## Methods Pati